Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-04

Clinical Trial Update: Melatonin and Sleep in Preventing Delirium in the Hospital [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial investigating melatonin for preventing delirium in hospitalized patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Scripps Health | Conditions: Delirium | Phase 1, Phase 2 | Status: COMPLETED